First Allied Advisory Services’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $206K | Sell |
3,786
-300
| -7% | -$16.3K | 0.01% | 1058 |
|
|
2020
Q2 | $210K | Sell |
4,086
-435
| -10% | -$22.4K | 0.01% | 979 |
|
|
2020
Q1 | $203K | Sell |
4,521
-1,590
| -26% | -$71.4K | 0.01% | 929 |
|
|
2019
Q4 | $326K | Sell |
6,111
-2,637
| -30% | -$141K | 0.01% | 897 |
|
|
2019
Q3 | $409K | Sell |
8,748
-15
| -0.2% | -$701 | 0.01% | 754 |
|
|
2019
Q2 | $441K | Buy |
8,763
+585
| +7% | +$29.4K | 0.02% | 726 |
|
|
2019
Q1 | $419K | Sell |
8,178
-18
| -0.2% | -$922 | 0.01% | 731 |
|
|
2018
Q4 | $387K | Sell |
8,196
-306
| -4% | -$14.4K | 0.02% | 689 |
|
|
2018
Q3 | $478K | Buy |
8,502
+2,124
| +33% | +$119K | 0.02% | 741 |
|
|
2018
Q2 | $325K | Sell |
6,378
-63
| -1% | -$3.21K | 0.01% | 844 |
|
|
2018
Q1 | $319K | Sell |
6,441
-348
| -5% | -$17.2K | 0.01% | 839 |
|
|
2017
Q4 | $351K | Buy |
6,789
+57
| +0.8% | +$2.95K | 0.01% | 802 |
|
|
2017
Q3 | $355K | Hold |
6,732
| – | – | 0.02% | 742 |
|
|
2017
Q2 | $351K | Buy |
6,732
+2,076
| +45% | +$108K | 0.02% | 755 |
|
|
2017
Q1 | $234K | Sell |
4,656
-1,878
| -29% | -$94.4K | 0.01% | 914 |
|
|
2016
Q4 | $308K | Sell |
6,534
-147
| -2% | -$6.93K | 0.02% | 773 |
|
|
2016
Q3 | $333K | Buy |
6,681
+246
| +4% | +$12.3K | 0.02% | 703 |
|
|
2016
Q2 | $307K | Hold |
6,435
| – | – | 0.02% | 730 |
|
|
2016
Q1 | $296K | Sell |
6,435
-192
| -3% | -$8.83K | 0.02% | 745 |
|
|
2015
Q4 | $359K | Sell |
6,627
-192
| -3% | -$10.4K | 0.02% | 706 |
|
|
2015
Q3 | $337K | Sell |
6,819
-879
| -11% | -$43.4K | 0.02% | 694 |
|
|
2015
Q2 | $447K | Buy |
7,698
+2,826
| +58% | +$164K | 0.02% | 646 |
|
|
2015
Q1 | $284K | Buy |
+4,872
| New | +$284K | 0.02% | 804 |
|